AP
BSX icon

Atwood & Palmer’s Boston Scientific BSX Stock Holding History

Atwood & Palmer’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$811 Hold
19
– – ﹤0.01% 462
2026
Q1 		$1.19K Hold
19
– – ﹤0.01% 464
2025
Q4 		$1.81K Hold
19
– – ﹤0.01% 449
2025
Q3 		$1.85K Hold
19
– – ﹤0.01% 448
2025
Q2 		$2.04K Hold
19
– – ﹤0.01% 467
2025
Q1 		$1.92K Sell
19
-184
-91% -$18.5K ﹤0.01% 396
2024
Q4 		$18.1K Sell
203
-6
-3% -$528 ﹤0.01% 297
2024
Q3 		$17.5K Buy
209
+190
+1,000% +$15K ﹤0.01% 300
2024
Q2 		$1.46K Sell
19
-65
-77% -$4.76K ﹤0.01% 405
2024
Q1 		$5.75K Buy
84
+65
+342% +$4.18K ﹤0.01% 334
2023
Q4 		$1.1K Buy
+19
New +$1.01K ﹤0.01% 378

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Atwood & Palmer's BSX Position: Q2 2026 in Review

Atwood & Palmer held its Boston Scientific (BSX) position steady in Q2 2026 at 19 shares worth $811. The position accounts for ﹤0.01% of the portfolio, ranked #462.

Atwood & Palmer first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $18.1K in Q4 2024. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Atwood & Palmer held 19 shares of Boston Scientific worth $811 as of Q2 2026.
  • Atwood & Palmer left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Atwood & Palmer's portfolio in Q2 2026, its #462 holding.
  • Atwood & Palmer first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Atwood & Palmer's Boston Scientific position peaked at $18.1K in Q4 2024.
  • 338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.